SK6342000A3 - 6,11-bridged erythromycin derivatives - Google Patents

6,11-bridged erythromycin derivatives Download PDF

Info

Publication number
SK6342000A3
SK6342000A3 SK634-2000A SK6342000A SK6342000A3 SK 6342000 A3 SK6342000 A3 SK 6342000A3 SK 6342000 A SK6342000 A SK 6342000A SK 6342000 A3 SK6342000 A3 SK 6342000A3
Authority
SK
Slovakia
Prior art keywords
compound
formula
heteroarylene
arylene
group
Prior art date
Application number
SK634-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Yat Sun Or
George Griesgraber
Leping Li
Daniel T Chu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of SK6342000A3 publication Critical patent/SK6342000A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SK634-2000A 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives SK6342000A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96040097A 1997-10-29 1997-10-29
US15826998A 1998-09-22 1998-09-22
PCT/US1998/022941 WO1999021864A1 (en) 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives

Publications (1)

Publication Number Publication Date
SK6342000A3 true SK6342000A3 (en) 2000-09-12

Family

ID=26854886

Family Applications (1)

Application Number Title Priority Date Filing Date
SK634-2000A SK6342000A3 (en) 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives

Country Status (23)

Country Link
EP (1) EP1027361B1 (da)
JP (1) JP2001521038A (da)
KR (1) KR20010031591A (da)
CN (1) CN1278266A (da)
AR (1) AR015986A1 (da)
AT (1) ATE239750T1 (da)
AU (1) AU1286799A (da)
BG (1) BG104425A (da)
BR (1) BR9813317A (da)
CA (1) CA2307828A1 (da)
CO (1) CO4990972A1 (da)
DE (1) DE69814441T2 (da)
DK (1) DK1027361T3 (da)
ES (1) ES2198766T3 (da)
HU (1) HUP0004323A2 (da)
IL (1) IL134996A0 (da)
NO (1) NO20002099L (da)
PL (1) PL340253A1 (da)
PT (1) PT1027361E (da)
SK (1) SK6342000A3 (da)
TR (1) TR200001140T2 (da)
TW (1) TW486485B (da)
WO (1) WO1999021864A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CN1589277A (zh) 2001-09-17 2005-03-02 奥索-麦克尼尔药品公司 6-o-氨基甲酸酯-11,12-内酯-酮内酯抗菌剂
AU2002346475A1 (en) 2001-12-05 2003-06-23 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7273853B2 (en) 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
AU2003229037B8 (en) * 2002-05-13 2009-07-02 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
US6753318B1 (en) * 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
EP1509538A1 (en) 2002-05-13 2005-03-02 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
US6841664B2 (en) 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
WO2005067564A2 (en) 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
US7265094B2 (en) 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
WO2005080408A1 (en) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7384922B2 (en) 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7589067B2 (en) 2005-10-12 2009-09-15 Enanta Pharmaceuticals, Inc. 6, 11-bridged tricyclic macrolides
US8273720B2 (en) 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US11673910B2 (en) 2017-04-28 2023-06-13 Zikani Therapeutics, Inc. Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2218604T3 (es) * 1995-11-08 2004-11-16 Abbott Laboratories Derivados triciclicos de eritromicina.

Also Published As

Publication number Publication date
IL134996A0 (en) 2001-05-20
CN1278266A (zh) 2000-12-27
WO1999021864A1 (en) 1999-05-06
NO20002099D0 (no) 2000-04-25
TR200001140T2 (tr) 2001-05-21
EP1027361A1 (en) 2000-08-16
AU1286799A (en) 1999-05-17
TW486485B (en) 2002-05-11
ES2198766T3 (es) 2004-02-01
JP2001521038A (ja) 2001-11-06
DE69814441D1 (de) 2003-06-12
AR015986A1 (es) 2001-05-30
HUP0004323A2 (hu) 2001-02-28
NO20002099L (no) 2000-06-29
EP1027361B1 (en) 2003-05-07
BG104425A (bg) 2001-01-31
PL340253A1 (en) 2001-01-29
PT1027361E (pt) 2003-09-30
BR9813317A (pt) 2000-08-22
CA2307828A1 (en) 1999-05-06
ATE239750T1 (de) 2003-05-15
CO4990972A1 (es) 2000-12-26
DE69814441T2 (de) 2004-04-08
DK1027361T3 (da) 2003-08-25
KR20010031591A (ko) 2001-04-16

Similar Documents

Publication Publication Date Title
US6046171A (en) 6,11-bridged erythromycin derivatives
SK285535B6 (sk) 6-O-Substituované ketolidy s antibakteriálnou aktivitou, farmaceutická kompozícia s ich obsahom, ich použitie a spôsob ich prípravy
CZ303573B6 (cs) 6-O-substituovaný ketolidový derivát erythromycinu, jeho použití, farmaceutická kompozice ho obsahující a zpusob jeho výroby
EP1027361B1 (en) 6,11-bridged erythromycin derivatives
AU737310B2 (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
SK3032000A3 (en) 6,9-bridged erythromycin derivatives
SK286397B6 (sk) 2-Halogén-6-O-substituované ketolidové deriváty, ich použitie, spôsob ich prípravy a farmaceutické kompozície s ich obsahom
US6420535B1 (en) 6-O-carbamate ketolide derivatives
US6034069A (en) 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US6946446B2 (en) Anti-infective agents useful against multidrug-resistant strains of bacteria
CA2301642A1 (en) 3-descladinose 6-o-substituded erythromycin derivatives
EP1181300B1 (en) 6-o-carbamate ketolide derivatives
JP2003501439A5 (da)
EP1259923B1 (en) Anti-infective agents useful against mulitidrug-resistant strains of bacteria
CZ20001394A3 (cs) Erythromycinové deriváty s 6,11-přemostěním
SK160299A3 (en) Multicyclic erythromycin derivatives
KR19990067333A (ko) 에리트로마이신 a 및 b의 3-데옥시-3-데스클라디노즈 유도체
MXPA00004227A (en) 6,11-bridged erythromycin derivatives
MXPA00002216A (en) 3-descladinose 6-o-substituded erythromycin derivatives
CZ20001045A3 (cs) 3-N-módilikováné 6-O-substituované ketolidové deriváty erytromycinu
CZ2000811A3 (cs) 6,9-můstkové erythromycinové deriváty a způsob jejich přípravy
MXPA00003117A (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity